The Clinical Center of Montenegro (KCCG) announced that a patient was hospitalized at the Cardiology Clinic due to a deterioration in his health condition, after he repeatedly used the drug on his own initiative with the intention of reducing body weight.
According to the doctors' knowledge so far, the condition for which the patient was hospitalized is not a direct consequence of the use of this preparation, but its use could have contributed to the deterioration of the health condition.
"This is retatrutide, a substance that, according to the patient, was purchased online, and which is still in the clinical trial phase and has not been approved for public use. Retatrutide is being developed by an American company, and according to available information, its safety and efficacy are still being tested and it has not been approved by the US Food and Drug Administration (FDA) or other regulatory agencies," they point out in the statement.
An additional problem, they said, is the fact that KCCG doctors do not have reliable information about the composition of the preparation the patient used.
They note that preparations purchased outside legal channels may be of unverified composition, quality, and origin, and may contain substances not listed on the packaging.
KCCG urges citizens not to use any medication on their own, without prior advice and recommendation from a doctor, regardless of the reason for taking it. Special caution is necessary, they emphasize, when it comes to preparations that are not registered and approved for use or are purchased through social networks, the internet and other illegal channels.
"Health should not be trusted with untested preparations. The choice and application of therapy should always be decided by a doctor, after assessing the patient's health condition," the statement reads.
See more:
Download the app and follow the news
FOLLOW US ON